Fig. 1 | Signal Transduction and Targeted Therapy

Fig. 1

From: Novel therapeutic evaluation biomarkers of lipid metabolism targets in uncomplicated pulmonary tuberculosis patients

Fig. 1

Establishment and validation of OPLS-DA model (TB0 group vs. HC group), and screening of differential lipids. a The OPLS-DA model was able to separate the TB0 group from HC group clearly based on the selected lipid metabolites. b The model had good prediction ability, permutation test showed that R2X (cum) = 0.563, R2Y(cum) = 0.964, Q2(cum) = 0.822. c The differential lipids between the two groups were identified by volcanic map. The abscissa showed the different fold changes (logFC) of each lipid substance in different groups, the ordinate showed VIP value, and the different scatter colors and shapes represented the screening results of different lipid categories

Back to article page